Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice

Br J Cancer. 2008 Nov 18;99(10):1729-34. doi: 10.1038/sj.bjc.6604681. Epub 2008 Sep 30.

Abstract

At present no reports on gene expression profiling of liver metastases from colorectal cancer are available. We identified two different signatures using Affymetrix platform: epidermal growth factor receptor pathway was upregulated in metachronous lesions, whereas the pathway mainly related to angiogenesis was in synchronous lesions. Synchronous or metachronous liver metastases could be treated differently on the basis of different molecular pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / genetics
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • ErbB Receptors / genetics
  • Female
  • Gene Expression Profiling*
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Second Primary / genetics

Substances

  • Biomarkers, Tumor
  • ErbB Receptors